Intralymphatic specific immunotherapy - as a new treatment for grass pollen allergy sufferers. [Intralymfatisk specifik immunterapi - som ny behandlingsmetode til graespollenallergikere].

Trial Profile

Intralymphatic specific immunotherapy - as a new treatment for grass pollen allergy sufferers. [Intralymfatisk specifik immunterapi - som ny behandlingsmetode til graespollenallergikere].

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Apr 2013

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Grass pollen hypersensitivity
  • Focus Therapeutic Use
  • Acronyms ILIT
  • Most Recent Events

    • 09 Feb 2013 Status changed from recruiting to completed.
    • 28 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top